SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-036400
Filing Date
2020-08-05
Accepted
2020-08-05 06:30:46
Documents
66
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q krtx-10q_20200630.htm 10-Q 1955666
2 EX-31.1 krtx-ex311_8.htm EX-31.1 9446
3 EX-31.2 krtx-ex312_6.htm EX-31.2 9427
4 EX-32.1 krtx-ex321_7.htm EX-32.1 8505
  Complete submission text file 0001564590-20-036400.txt   6343492

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT krtx-20200630.xml EX-101.INS 1157262
6 XBRL TAXONOMY EXTENSION SCHEMA krtx-20200630.xsd EX-101.SCH 51419
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE krtx-20200630_cal.xml EX-101.CAL 56370
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krtx-20200630_def.xml EX-101.DEF 178212
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE krtx-20200630_lab.xml EX-101.LAB 404946
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krtx-20200630_pre.xml EX-101.PRE 315893
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38958 | Film No.: 201075527
SIC: 2834 Pharmaceutical Preparations